300267Hunan Er-Kang Pharmaceutical300267 info
$0.31info-4.42%24h
Global rank10104
Market cap$629.21M
Change 7d-2.70%
YTD Performance-32.92%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Hunan Er-Kang Pharmaceutical (300267) Stock Overview

    Hunan Er-Kang Pharmaceutical Co., Ltd manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally. Its APIs include glycerin, dilute hydrochloric acid, sulbenicillin sodium, dihydroxypropyl theophylline, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's finished drugs primarily comprise sulbenicillin sodium for injection and compound liquorice tablets. Its conventional pharmaceutical excipients include pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprise hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate and its series products. Hunan Er-Kang Pharmaceutical Co., Ltd was founded in 2003 and is based in Changsha, China.

    300267 Stock Information

    Symbol
    300267
    Address
    No. 167Changsha, 410331China
    Founded
    -
    Trading hours
    -
    Website
    https://www.hnerkang.com
    Country
    ๐Ÿ‡จ๐Ÿ‡ณ China
    Phone Number
    86 731 8465 9108

    Hunan Er-Kang Pharmaceutical (300267) Price Chart

    -
    Value:-

    Hunan Er-Kang Pharmaceutical Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.30505458499865834
    N/A
    Market Cap
    $629.21M
    N/A
    Shares Outstanding
    2.06B
    N/A
    Employees
    1.50K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    ยฉ 2024 Topstocks.org